Identifying patterns in treatment response profiles in acute bipolar mania: a cluster analysis approach

Lipkovich, Ilya A.; Houston, John P.; Ahl, Jonna
January 2008
BMC Psychiatry;2008, Vol. 8, Special section p1
Academic Journal
Background: Patients with acute mania respond differentially to treatment and, in many cases, fail to obtain or sustain symptom remission. The objective of this exploratory analysis was to characterize response in bipolar disorder by identifying groups of patients with similar manic symptom response profiles. Methods: Patients (n = 222) were selected from a randomized, double-blind study of treatment with olanzapine or divalproex in bipolar I disorder, manic or mixed episode, with or without psychotic features. Hierarchical clustering based on Ward's distance was used to identify groups of patients based on Young-Mania Rating Scale (YMRS) total scores at each of 5 assessments over 7 weeks. Logistic regression was used to identify baseline predictors for clusters of interest. Results: Four distinct clusters of patients were identified: Cluster 1 (n = 64): patients did not maintain a response (YMRS total scores ≤ 12); Cluster 2 (n = 92): patients responded rapidly (within less than a week) and response was maintained; Cluster 3 (n = 36): patients responded rapidly but relapsed soon afterwards (YMRS ≥ 15); Cluster 4 (n = 30): patients responded slowly (≥ 2 weeks) and response was maintained. Predictive models using baseline variables found YMRS Item 10 (Appearance), and psychosis to be significant predictors for Clusters 1 and 4 vs. Clusters 2 and 3, but none of the baseline characteristics allowed discriminating between Clusters 1 vs. 4. Experiencing a mixed episode at baseline predicted membership in Clusters 2 and 3 vs. Clusters 1 and 4. Treatment with divalproex, larger number of previous manic episodes, lack of disruptive-aggressive behavior, and more prominent depressive symptoms at baseline were predictors for Cluster 3 vs. 2. Conclusion: Distinct treatment response profiles can be predicted by clinical features at baseline. The presence of these features as potential risk factors for relapse in patients who have responded to treatment should be considered prior to discharge. Trial registration: The clinical trial cited in this report has not been registered because it was conducted and completed prior to the inception of clinical trial registries.


Related Articles

  • Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Tohen, M.; Chengappa, K. N. R.; Suppes, T.; Baker, R. W.; Zarate, C. A.; Bowden, C. L.; Sachs, G. S.; Kupfer, D. J.; Ghaemi, S. N.; Feldman, P. D.; Risser, R. C.; Evans, A. R.; Calabrese, J. R.; Tohen, Mauricio; Chengappa, K N Roy; Suppes, Trisha; Baker, Robert W; Zarate, Carlos A; Bowden, Charles L; Sachs, Gary S // British Journal of Psychiatry;Apr2004, Vol. 184, p337 

    Background: Few controlled studies have examined the use of atypical antipsychotic drugs for prevention of relapse in patients with bipolar I disorder. Aims To evaluate whether olanzapine plus either lithium or valproate reduces the rate of relapse, compared with lithium or...

  • olanzapine.  // Taber's Cyclopedic Medical Dictionary;2005, p1514 

    A definition of the term "olanzapine" is presented. It refers to an atypical antipsychotic agent used to treat psychosis and schizophrenia. Olanzapine controls both the positive and negative symptoms of schizophrenia. Extrapyramidal side effects are less commonly linked with the use of...

  • Comparably high retention and low relapse rates in different subpopulations of bipolar patients in a German non-interventional study. Kraemer, Susanne; Minarzyk, Anette; Eppendorfer, Steffen; Henneges, Carsten; Hundemer, Hans-Peter; Wilhelm, Stefan; Grunze, Heinz // BMC Psychiatry;2013, Vol. 13 Issue 1, p1 

    Background: Although a range of pharmacotherapeutical options are available for the treatment of bipolar disorder, patient non-adherence to prescribed treatment regimens and early treatment discontinuation remain among the primary obstacles to effective treatment. Therefore, this observational...

  • Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study. Pei-Yin Pan; Meei-Shyuan Lee; Miao-Chi Lo; En-Lin Yang; Chin-Bin Yeh // BMC Psychiatry;2014, Vol. 14 Issue 1, p117 

    Background Bipolar disorder is a highly recurrent disease and has great impact on the function of patients. Depressive symptoms consist of more than 50% of life time during the illness and may lead to self harm or suicidal behaviors. Little is known about the antidepressant effects of...

  • Efficacy and Clinical Determinants of Antipsychotic Polypharmacy in Psychotic Patients Experiencing an Acute Relapse and Admitted to Hospital Stay: Results from a Cross-Sectional and a Subsequent Longitudinal Pilot Study. Iasevoli, Felice; Buonaguro, Elisabetta F.; Marconi, Massimo; Di Giovambattista, Emanuela; Rapagnani, Maria Paola; De Berardis, Domenico; Martinotti, Giovanni; Mazza, Monica; Balletta, Raffaele; Serroni, Nicola; Di Giannantonio, Massimo; de Bartolomeis, Andrea; Valchera, Alessandro // ISRN Otolaryngology;2014, p1 

    Background. Antipsychotic polypharmacy is used in several psychiatric disorders, despite poor evidence existing to support this practice. Aim. We evaluated whether psychotic patients in acute relapse exposed to antipsychotic polypharmacy (AP + AP) showed different demographic, clinical, or...

  • A 55-year-old Man With Long-term Refractory Depression. Fawcett, Jan // Psychiatric Annals;Jun2006, Vol. 36 Issue 6, p384 

    The article offers information on a case study of a 55-year-old man with a treatment-resistant bipolar I depression which lasted for more than 15 years. Treatment options had to be considered for recurrences of the depression and cognitive impairment due to strong anticholinergic effects of...

  • Level of Insight in Patients With Obsessive–Compulsive Disorder: An Exploratory Comparative Study Between Patients With "Good Insight" and "Poor Insight". de Avila, Richard Chuquel Silveira; do Nascimento, Laura Gratsch; Porto, Rafaella Landell de Moura; Fontenelle, Leonardo; Filho, Eurípedes Constantino Miguel; Brakoulias, Vlasios; Ferrão, Ygor Arzeno // Frontiers in Psychiatry;7/3/2019, p1 

    Introduction: Insight may be defined as the ability to perceive and evaluate external reality and to separate it from its subjective aspects. It also refers to the ability to self-assess difficulties and personal qualities. Insight may be a predictor of success in the treatment of...

  • Treatment of bipolar disorder: a systematic review of available data. Fountoulakis, Konstantinos; Vieta, Eduard; Kaprinis, George // Annals of General Psychiatry;2008 Supplement 1, Vol. 7, Special section p1 

    Background The current article is a systematic review of the data available concerning the treatment of bipolar disorder. Materials and methods A systematic MEDLINE search concerning treatment guidelines and clinical trials. Results The search for treatment guidelines returned 370 articles and...

  • The promise of new drugs for schizophrenia treatment. Tamminga, C. A.; Tamminga, Ca // Canadian Journal of Psychiatry;Apr1997, Vol. 42 Issue 3, p265 

    Objective: To present aspects of preclinical and clinical pharmacology of new antipsychotic drugs and to emphasize those preclinical drug characteristics which might predict desirable clinical actions.Method: Review of the relevant literature and publicly presented...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics